Oracle CORP Form 4 insider transactions

Oracle's EVP, Chief Accounting Officer, Maria Smith, was granted 35,706 restricted stock units, vesting over four years.

Oracle's EVP and Chief Legal Officer, Stuart Levey, acquired additional restricted stock units, including dividend equivalents and new grants, as part of his compensation.

Oracle's EVP, Chief Accounting Officer Maria Smith, sold 10,000 shares of common stock in two separate transactions under a pre-arranged Rule 10b5-1 trading plan.

Oracle's Chief Executive Officer, Clayton M. Magouyrk, sold 40,000 shares of common stock for approximately $11.06 million under a pre-arranged 10b5-1 trading plan.

Oracle's EVP and Chief Legal Officer, Stuart Levey, sold 19,758 shares of common stock for $300 per share under a pre-arranged 10b5-1 plan.

Oracle Director Naomi O. Seligman reported selling 2,222 shares and gifting 1,406 shares of common stock on September 26, 2025.

Oracle's Chief Executive Officer, Michael D. Sicilia, was granted 1,037,412 stock options with an exercise price of $308.46, vesting annually over four years.

Oracle CEO Clayton M. Magouyrk was granted 2,593,530 stock options with an exercise price of $308.46, vesting annually over four years.

Oracle President Michael Sicilia reported routine stock acquisitions and sales, including tax-related withholdings and planned dispositions under a 10b5-1 plan.

Oracle Vice Chairman Jeffrey Henley reported the vesting of restricted stock units and subsequent tax-related share dispositions.

Oracle's EVP, Chief Accounting Officer, Maria Smith, reported the vesting of restricted stock units into common stock and subsequent sales to cover tax liabilities.

Clayton M. Magouyrk, President of Oracle's OCI, exercised restricted stock units and subsequently sold a portion of the acquired shares to cover tax obligations.

Oracle's EVP, Chief Legal Officer, Stuart Levey, reported the vesting of restricted stock units and subsequent share disposition for tax obligations.

Oracle's EVP and Chief Accounting Officer, Maria Smith, reported the vesting and subsequent tax-related sale of company common stock.

Oracle's President of Industries, Michael D. Sicilia, reported the vesting of 52,673 restricted stock units, followed by tax-related share withholding and an open market sale of 16,323 common shares.

Oracle's EVP and Chief Legal Officer, Stuart Levey, reported the vesting of restricted stock units and a subsequent sale of shares to cover tax liabilities.

Oracle Vice Chairman Jeffrey Henley reported the vesting of restricted stock units and a subsequent tax-related sale of company common stock.

Oracle Corp. Director William G. Parrett reported a planned future sale of 11,500 shares of common stock at $306 per share under a Rule 10b5-1 plan.

Oracle's President of OCI, Clayton M. Magouyrk, reported selling common stock and vesting restricted stock units.

Oracle's President of OCI, Clayton M. Magouyrk, reported the vesting of 62,500 restricted stock units and the subsequent sale of shares to cover tax liabilities.

Oracle's President of Industries, Michael D. Sicilia, reported recent stock acquisitions, sales, and RSU vesting, adjusting his beneficial ownership.

Oracle's EVP and Chief Accounting Officer, Maria Smith, converted 3,375 restricted stock units into common stock and subsequently sold 1,759 shares to cover tax liabilities.

Jeffrey Henley, Oracle's Vice Chairman, reported the acquisition of shares through RSU vesting and a sale to cover tax obligations.

Oracle's EVP and Chief Legal Officer, Stuart Levey, reported the acquisition of 164.522 restricted stock units representing deferred dividend equivalents.

Oracle Corporation Director Naomi O. Seligman sold 3,303 shares of common stock at $233.32 per share, a transaction executed under a Rule 10b5-1 pre-planned trading arrangement.

Oracle's Executive Chairman and CTO, Lawrence Joseph Ellison, exercised stock options to acquire 6.5 million shares of common stock at $51.13 per share, following the certification of performance goals by the Compensation Committee.

Lawrence Joseph Ellison, Oracle's Executive Chairman and Chief Technology Officer, exercised 6 million performance-based stock options valued at over $306 million, significantly increasing his direct beneficial ownership in the company.

Oracle Corp Director Rona Alison Fairhead purchased 480 shares of common stock at $233.87 per share on July 7, 2025, increasing her direct and indirect beneficial ownership.

Oracle's EVP and Chief Accounting Officer, Maria Smith, sold 10,000 shares of common stock for approximately $2.33 million under a Rule 10b5-1 plan.

Oracle CEO Safra Catz reported the exercise of stock options and subsequent sale of 1,260,508 shares of Oracle common stock on June 27, 2025, executed under a Rule 10b5-1 trading plan.